tiprankstipranks
STRATEC Biomedical AG (DE:SBS)
XETRA:SBS
Germany Market

STRATEC Biomedical (SBS) Financial Statements

Compare
3 Followers

STRATEC Biomedical Financial Overview

STRATEC Biomedical's market cap is currently €365.89M. The company's EPS TTM is €0.823; its P/E ratio is 36.55; and it has a dividend yield of 1.92%. STRATEC Biomedical is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue€ 261.91M€ 274.63M€ 287.33M€ 250.10M€ 221.64M
Gross Profit€ 64.84M€ 79.49M€ 87.71M€ 68.99M€ 52.10M
Operating Income€ 22.89M€ 41.78M€ 50.78M€ 32.48M€ 19.11M
EBITDA€ 39.82M€ 57.53M€ 65.45M€ 52.59M€ 36.09M
Net Income€ 13.07M€ 29.22M€ 39.96M€ 25.18M€ 14.44M
Balance Sheet
Cash & Short-Term Investments€ 34.22M€ 24.07M€ 48.72M€ 39.15M€ 24.03M
Total Assets€ 466.58M€ 397.50M€ 368.52M€ 331.90M€ 299.41M
Total Debt€ 141.37M€ 87.15M€ 85.30M€ 109.58M€ 93.26M
Net Debt€ 107.84M€ 64.48M€ 38.11M€ 72.02M€ 70.55M
Total Liabilities€ 233.25M€ 172.32M€ 162.77M€ 159.36M€ 140.41M
Stockholders' Equity€ 233.33M€ 225.18M€ 205.76M€ 172.54M€ 159.01M
Cash Flow
Free Cash Flow€ 2.00M€ -8.74M€ 43.24M€ 6.27M€ -5.58M
Operating Cash Flow€ 19.43M€ 10.28M€ 63.47M€ 31.85M€ 21.26M
Investing Cash Flow€ -44.16M€ -19.00M€ -20.13M€ -21.84M€ -27.72M
Financing Cash Flow€ 35.44M€ -14.11M€ -34.33M€ 5.22M€ 5.45M
Currency in EUR

STRATEC Biomedical Earnings and Revenue History

STRATEC Biomedical Debt to Assets

STRATEC Biomedical Cash Flow

STRATEC Biomedical Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis